Brovana and Perforomist will be the first long-acting beta-2 agonists that come in solutions for nebulizers

June 2007

Brovana and Perforomist will be the first long-acting beta-2 agonists that come in solutions for nebulizers.

Both will be used for treating COPD.

Brovana (arformoterol) is an isomer of formoterol...the long-acting beta-2 agonist in Foradil and Symbicort inhalers.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote